ClinicalTrials.gov
public full text
Public Domain
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma#1088068
- Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy#1030136
- γ-irradiated BCG to Train Innate Immunity#18680
- EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway#379314
- TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma#201713
Record · ID 454020
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive